David A. Robins - Co-Ceo



 

David Robins joined DavosPharma in 1995. He began his chemistry career with Bristol Myers Squibb in 1991 as a process engineer at the Syracuse pilot plant. In this position, he worked on process development and the scale-up of clinical candidates involving: beta lactams, recombinant enzymes, mAbs, semi-synthetic cytotoxins, and small molecules.

​At DavosPharma, Dave Robins is responsible for the supply chain and project management of new NCEs for emerging Biotechs. A number of his projects have resulted in successful drug launches. Mr. Robins holds a B.Sc. in Engineering Chemistry from Queen's University, Kingston, Ontario, and a M.S. in Chemical Engineering from Syracuse University.